Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.35
- Piotroski Score 2.00
- Grade Speculative Buy
- Symbol (INTS)
- Company Intensity Therapeutics, Inc.
- Price $3.56
- Changes Percentage (-6.81%)
- Change -$0.26
- Day Low $3.56
- Day High $3.82
- Year High $11.44
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. The company's lead product candidate is INT230-6, which is in Phase 2 clinical trial for the treatment of refractory solid tumors; and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. It has a collaboration agreement with Merck Sharpe & Dohme Corp. to evaluate the combination of INT230-6 and Keytruda in patients with advanced pancreatic, colon, squamous cell, and bile duct malignancies; Bristol-Myers Squibb Company to evaluate the combination of INT230-6 with Yervoy in patients with advanced liver, breast, and sarcoma cancers; and Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research to study INT230-6 in a randomized controlled neoadjuvant phase II study in women with early-stage breast cancer. The company was founded in 2012 and is headquartered in Westport, Connecticut.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.10
- Trailing P/E Ratio -4.35
- Forward P/E Ratio -4.35
- P/E Growth -4.35
- Net Income $-10,538,000
Income Statement
Quarterly
Annual
Latest News of INTS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Fantasy basketball 2024-25 draft cheat sheet: Top 150 players for roto, head-to-head and points leagues
Get ready for fantasy basketball season with annual Top 150 player rankings. Check out rankings for different league formats: roto, H2H, and points-based. Keep an eye on updates before mid-late Octobe...
By The New York Times | 23 hours ago -
'Wordle' #1,200 hints, clues and answer for Tuesday, October 1 game
Wordle, created by Josh Wardle, has gained immense popularity as a daily word game, attracting over 2 million players in a short time. The game's charm lies in its daily challenge format, fostering a ...
By Newsweek | 1 day ago -
Saints' flattering stats belie game-changing gaffes and failures in the clutch
The New Orleans Saints have shown strong performances but struggle to close out games, resulting in close losses despite statistical advantages. Key mistakes and injuries have impacted their recent ga...
By AP NEWS | 1 day ago